The emerging era of personalized medicine in advanced colorectal cancer-Reference-Cited by-同舟云学术

The emerging era of personalized medicine in advanced colorectal cancer

Published:2022-07-20 Issue:8 Volume:37 Page:1411-1425
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Wu Claudia W K¹²,Reid Madeleine³⁴,Leedham Simon³⁴,Lui Rashid N¹²⁵^ORCID

Affiliation:

1. Institute of Digestive Disease Chinese University of Hong Kong Hong Kong China

2. Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics Prince of Wales Hospital Hong Kong China

3. Translational Gastroenterology Unit, John Radcliffe hospital University of Oxford Oxford UK

4. Wellcome Centre for Human Genetics, Nuffield Department of Medicine University of Oxford Oxford UK

5. Department of Clinical Oncology Chinese University of Hong Kong Hong Kong China

Funder

Wellcome Trust

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15937

Reference205 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

2. Prevalence and risk factors of colorectal cancer in Asia

3. Global patterns and trends in colorectal cancer incidence and mortality

4. Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer

5. Cancer of the colon and rectum ‐ cancer stat facts [Internet]. SEER. [cited2022Apr 24]. Available from:https://seer.cancer.gov/statfacts/html/colorect.html

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in Clinicopathological Features, P16Ink4a and P57KIP2 Immunohistochemical Expressions, and Survival Between Colorectal Carcinoma in Rectosigmoid and Other Colonic Locations;Cureus;2024-06-10

2. The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research;Pathology - Research and Practice;2024-02

3. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways;Medical Oncology;2023-10-19

4. Current Targeted Therapy for Metastatic Colorectal Cancer;International Journal of Molecular Sciences;2023-01-15

5. Curcumol Reduces Aerobic Glycolysis and Overcomes Chemoresistance by Inducing Cdh1-Mediated Skp2 Ubiquitination;The American Journal of Chinese Medicine;2023-01